D283Med Cells

The D283Med cell line is a human medulloblastoma cell line that was derived from the cerebellum of a 6-year-old male. Medulloblastoma is a type of primitive neuroectodermal tumor that primarily affects children and is located in the cerebellum, the part of the brain responsible for motor control and coordination. D283Med cells are widely used in oncological research, particularly in studies focused on the biology and pharmacology of medulloblastomas.

This cell line exhibits an adherent growth pattern and has been used extensively to explore the molecular pathways involved in medulloblastoma pathogenesis, such as the Sonic Hedgehog (SHH) and WNT signaling pathways, which are known to play significant roles in the development and progression of these tumors. Researchers utilize the D283Med line to assess therapeutic efficacy and resistance, study gene expression profiles, and explore novel therapeutic targets. The line’s robust growth and typical medulloblastoma genetic features make it a valuable model for preclinical studies aimed at understanding tumor biology and testing anticancer drugs.

Furthermore, D283Med cells are utilized in genetic studies to understand the impact of mutations and to assess mechanisms of metastasis and recurrence in medulloblastoma. They provide a crucial tool for the investigation of oncogenic processes at the cellular level, thereby contributing significantly to the development of targeted therapies for this aggressive pediatric brain tumor.